DE69333923D1 - Stabil transfizierte Zelllinien welche Gaba-A- Rezeptoren mit der Untereinheitenzusammensetzung alpha-3, beta-3 und gamma-2 exprimieren - Google Patents

Stabil transfizierte Zelllinien welche Gaba-A- Rezeptoren mit der Untereinheitenzusammensetzung alpha-3, beta-3 und gamma-2 exprimieren

Info

Publication number
DE69333923D1
DE69333923D1 DE69333923T DE69333923T DE69333923D1 DE 69333923 D1 DE69333923 D1 DE 69333923D1 DE 69333923 T DE69333923 T DE 69333923T DE 69333923 T DE69333923 T DE 69333923T DE 69333923 D1 DE69333923 D1 DE 69333923D1
Authority
DE
Germany
Prior art keywords
sub
receptors
gamma
beta
cell lines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69333923T
Other languages
English (en)
Other versions
DE69333923T2 (de
Inventor
Karen L Hadingham
Paul J Whiting
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Original Assignee
Merck Sharp and Dohme Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929225776A external-priority patent/GB9225776D0/en
Priority claimed from GB939318528A external-priority patent/GB9318528D0/en
Application filed by Merck Sharp and Dohme Ltd filed Critical Merck Sharp and Dohme Ltd
Publication of DE69333923D1 publication Critical patent/DE69333923D1/de
Application granted granted Critical
Publication of DE69333923T2 publication Critical patent/DE69333923T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69333923T 1992-12-10 1993-12-07 Stabil transfizierte Zelllinien welche Gaba-A- Rezeptoren mit der Untereinheitenzusammensetzung alpha-3, beta-3 und gamma-2 exprimieren Expired - Fee Related DE69333923T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB929225776A GB9225776D0 (en) 1992-12-10 1992-12-10 Cell line
GB9225776 1992-12-10
GB9318528 1993-09-07
GB939318528A GB9318528D0 (en) 1993-09-07 1993-09-07 Cell line

Publications (2)

Publication Number Publication Date
DE69333923D1 true DE69333923D1 (de) 2006-01-05
DE69333923T2 DE69333923T2 (de) 2006-08-03

Family

ID=26302133

Family Applications (3)

Application Number Title Priority Date Filing Date
DE69333923T Expired - Fee Related DE69333923T2 (de) 1992-12-10 1993-12-07 Stabil transfizierte Zelllinien welche Gaba-A- Rezeptoren mit der Untereinheitenzusammensetzung alpha-3, beta-3 und gamma-2 exprimieren
DE69320985T Expired - Fee Related DE69320985T2 (de) 1992-12-10 1993-12-07 Stabil transfizierte zelllinien welche gaba-a rezeptoren exprimieren
DE69334187T Expired - Fee Related DE69334187T2 (de) 1992-12-10 1993-12-07 Stabil transfizierte Zelllinien welche Humane GABA-A Rezeptoren mit der Untereinheitskombination Alpha-2, Beta-3 und Gamma-2 exprimieren

Family Applications After (2)

Application Number Title Priority Date Filing Date
DE69320985T Expired - Fee Related DE69320985T2 (de) 1992-12-10 1993-12-07 Stabil transfizierte zelllinien welche gaba-a rezeptoren exprimieren
DE69334187T Expired - Fee Related DE69334187T2 (de) 1992-12-10 1993-12-07 Stabil transfizierte Zelllinien welche Humane GABA-A Rezeptoren mit der Untereinheitskombination Alpha-2, Beta-3 und Gamma-2 exprimieren

Country Status (9)

Country Link
US (1) US5652100A (de)
EP (3) EP0856581B1 (de)
JP (1) JP3464672B2 (de)
AT (2) ATE170921T1 (de)
AU (1) AU680852B2 (de)
DE (3) DE69333923T2 (de)
DK (1) DK0856581T3 (de)
ES (2) ES2296064T3 (de)
WO (1) WO1994013799A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9420010D0 (en) * 1994-10-01 1994-11-16 Marck Sharp & Dohme Limited Nucleic acids
GB9503601D0 (en) 1995-02-23 1995-04-12 Merck Sharp & Dohme Method of treatment and method of manufacture of medicament
WO1997017369A2 (en) * 1995-11-09 1997-05-15 Trustees Of Boston University Dna comprising a neuron-specific transcriptional promoter and its use in a gene therapy vector
EP0934528B1 (de) * 1996-10-25 2002-09-04 Neurosearch A/S Methode zur identifizierung von verbindungen mit anxiolytischem potential
JP2001505423A (ja) * 1996-11-25 2001-04-24 メルク シヤープ エンド ドーム リミテツド 新規クローン化ＧＡＢＡ受容体サブユニットｃＤＮＡ配列および安定にコトランスフェクトされた細胞系
GB9708479D0 (en) 1997-04-25 1997-06-18 Merck Sharp & Dohme Nucleic acids
US7029870B1 (en) 1997-07-03 2006-04-18 Human Genome Sciences, Inc. Gabaa receptor epsilon subunits
GB9715164D0 (en) * 1997-07-19 1997-09-24 Medical Res Council Improvements in or relating to expression of nucleic acid sequences in cerebellar cells
US6762294B2 (en) 1999-02-19 2004-07-13 The United States Of America As Represented By The Department Of Health And Human Services Polynucleotides encoding polymorphic human GABAA receptor α-6 subunit
DE60024231T2 (de) * 1999-02-19 2006-08-03 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Polymorphismus im gen für die menschliche gaba a rezeptor alpha 6 untereinheit
CA2425124A1 (en) * 2000-10-05 2002-04-11 Hanns Mohler Selective anxiolytic therapeutic agents
US7282344B2 (en) * 2001-06-06 2007-10-16 Neurosearch A/S Cation conducting GABAA receptors and their use
CA2625210A1 (en) * 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
NZ601353A (en) * 2008-02-01 2014-06-27 Chromocell Corp Cell lines and methods for making and using them
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
CN106854207B (zh) 2015-12-08 2019-10-29 上海赛默罗生物科技有限公司 呔嗪类衍生物、其制备方法、药物组合物和用途
US11512089B2 (en) 2018-03-12 2022-11-29 Shanghai SIMR Biotechnology Co., Ltd Substituted [1,2,4]triazolo[3,4-a]phthalazines as modulators of GABAA receptor activity
CN112979655A (zh) 2019-12-16 2021-06-18 上海赛默罗生物科技有限公司 三唑并哒嗪类衍生物、其制备方法、药物组合物和用途
IL310708A (en) 2021-08-12 2024-04-01 Shanghai Simr Biotechnology Co Ltd The history of converted triazole, a method for its preparation, its pharmaceutical preparation and its use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9112504D0 (en) * 1991-06-11 1991-07-31 Merck Sharp & Dohme Cell line
US5166066A (en) * 1991-07-11 1992-11-24 The Upjohn Company Transformed cells comprising GABAA receptors

Also Published As

Publication number Publication date
ES2296064T3 (es) 2008-04-16
ES2251011T3 (es) 2006-04-16
EP0673419B1 (de) 1998-09-09
EP1605046A1 (de) 2005-12-14
EP0856581A2 (de) 1998-08-05
DE69320985T2 (de) 1999-05-12
JPH08504330A (ja) 1996-05-14
DE69334187D1 (de) 2008-01-03
EP1605046B1 (de) 2007-11-21
EP0856581A3 (de) 1999-11-24
DK0856581T3 (da) 2006-03-27
EP0673419A1 (de) 1995-09-27
ATE170921T1 (de) 1998-09-15
AU680852B2 (en) 1997-08-14
AU5655494A (en) 1994-07-04
US5652100A (en) 1997-07-29
ATE311449T1 (de) 2005-12-15
DE69333923T2 (de) 2006-08-03
DE69334187T2 (de) 2008-10-09
DE69320985D1 (de) 1998-10-15
WO1994013799A1 (en) 1994-06-23
JP3464672B2 (ja) 2003-11-10
EP0856581B1 (de) 2005-11-30

Similar Documents

Publication Publication Date Title
DE69333923D1 (de) Stabil transfizierte Zelllinien welche Gaba-A- Rezeptoren mit der Untereinheitenzusammensetzung alpha-3, beta-3 und gamma-2 exprimieren
MX9305798A (es) Composiciones de lapiz labial humedecedor.
HUP9900605A3 (en) Lipopolyamines as transfection agents, preparation and use thereof and pharmaceutical compositions containing them
MX9707021A (es) Receptor de il-7.
CA2189250A1 (en) Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
TW347335B (en) Solid silicone compositions and methods for their preparation and use
ES2300276T3 (es) P40 de interleuquina-12 de mamifero e interleuquina b30. sus combinaciones. anticuerpos. usos en composiciones farmaceuticas.
DK463586A (da) Fsh
IL75986A (en) 3-(2-dimethylamino)ethyl)-n-methyl-1h-indole-5-methanesulphonamide,its preparation and pharmaceutical compositions containing it
CA2159013A1 (en) Non-aerosol shaving gel
AP2001002054A0 (en) Use of biogenic estrogen sulfamates for hormone replacement therapy.
DK0667768T3 (da) Anvendelse af toremifen til behandling af SLE
EP1258530A3 (de) Gaba-a Rezeptoruntereinheiten (alpha-2, alpha-3, alpha-5, alpha-6, beta-2) und transfektierte Zellen, die diese expremieren
EP0736600A3 (de) Verwendung von einem Immunschwäche unterdrückenden Virus welcher Lymphokine unterdrückt (ISL) zur Verhinderung der viralen Replikaten insbesondere der von Retroviren
WO1998038968A3 (de) Kosmetisches körperpflegepräparat das honig enthält und verfahren zu seiner herstellung
CA2148599A1 (en) Cdnas encoding human nmda-22a receptor subunit and isoforms of the human nmda-r1 receptor subunit, transfected cell line expressing them
IL86077A0 (en) Receptor of the small rhinovirus receptor group,its preparation and pharmaceutical compositions containing it
HUP9600517A3 (en) New tricyclic derivatives, their preparation, their use for the preparation of optically active or valemic colchicine and thiocolchine and analogues and derivatives and intermediates
CA2151236A1 (en) Stably transfected cell lines expressing gaba-a receptors
HUP0004362A2 (hu) Karbamazepint vagy származékait tartalmazó parenterális készítmények
HUP9903619A2 (hu) 5HT2c Antagonistát és D2 antagonistát tartalmazó gyógyszerkészítmény
NZ217356A (en) Benzamide derivatives and pharmaceutical compositions
IT8521528A0 (it) Composizioni farmaceutiche e cosmetiche contenenti come ingrediente attivo diidrossi-1,8fenil-10 antrone-9, e procedimentodi preparazione dell'ingrediente attivo.
CA2143325A1 (en) Cloning and expression of .beta.app-c100 receptor
AU7011896A (en) Human hypothalmic ("hr") receptor polypeptide compositions, methods and uses thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee